Commissurotomy Aortic Transventricular

Aortic transventricular commissurotomy is a surgical procedure performed to treat some forms of aortic stenosis. It involves removing part of the aorta (aortic commissure) through an opening in the ventricle of the heart.

Aortic stenosis is a narrowing of the aorta that can be caused by a variety of causes, including congenital abnormalities, rheumatic diseases, or atherosclerosis. With aortic stenosis, blood cannot flow freely through the aorta, which can lead to increased pressure in the heart and poor heart function.

Commissurotomy is an operation in which the surgeon removes part of the aorta through an opening in the wall of the ventricle. This allows you to increase the lumen of the aorta and improve blood flow.

The procedure is performed under general anesthesia and usually takes about 2-3 hours. After the operation, the patient is in the hospital for several days to monitor his condition.

After commissurotomy, patients may experience some side effects such as chest pain, shortness of breath and dizziness. However, these symptoms usually go away within a few weeks.

Overall, commissurotomy is an effective treatment for aortic stenosis and can significantly improve patients' quality of life.

Aortic Transventricular commissurotomy (lat. commissurotomia aoeritalis transventricularis) is one of the types of surgical treatment for aortic stenosis.

Unlike commissurotomy or valvotomy, this operation is much more radical and is performed only in cases where there are pronounced deformations and changes in the cavity of the left ventricle and the valves are severely affected. A commissurotome is a surgical instrument for performing such an operation. The operation consists of removing the interventricular septum and thinning the aortic valve leaflet to widen its vascular opening and improve blood flow.

The benefits of Commissurotammy surgery include the ability to restore normal circulation and improve the quality of life of patients with severe forms of aortic stenosis or aortic valve flow insufficiency. Over time, the prospects for a repeat procedure can be expected to increase significantly.

Among the disadvantages, it is worth noting the high complexity of the operation, serious blood loss and the risk of various complications, including arrhythmia, pericarditis, heart problems or thromboembolism, because it cannot be recommended for patients with underlying diseases. For example, if the patient has thyroid disease or severe liver disease, surgery will not be possible.